Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

8 results about "Skin Lightening Agent" patented technology

Hydroquinone is a skin-bleaching agent that is used to lighten areas of darkened skin such as freckles, chloasma (also known as melasma), age spots, and acne scars.

A biosafe skin lightening agent based on lysine synergistic system and method

The application belongs to the technical field of biomedical optical imaging, and more particularly relates to a biosafe skin optical clearing agent and method based on a lysine synergistic system. The biosafe skin optical clearing agent provided in the application contains lysine or a salt thereof as an active ingredient, can effectively reduce the light scattering of skin tissue, and thus realizes the optical clearing of skin, and meanwhile, the morphology of the skin tissue is well maintained during the treatment. The skin optical clearing agent has the advantages of simple active ingredient, high biosafety, remarkable skin optical clearing effect, convenient preparation, simple application operation and the like, and is suitable for the optical clearing treatment of ex vivo skin and in vivo skin.
Owner:HUAZHONG UNIV OF SCI & TECH

Composition for improving NAD < + > level and application of composition in improvement of skin photoaging

The invention belongs to the field of medicines and health foods, and particularly relates to a composition for improving the NAD < + > level and application of the composition in relieving skin light injury and light aging. The composition for improving the NAD < + > level comprises wheat polar fat and an oriental cherry extract, and can also comprise ergothioneine. All the components in the composition are reasonably matched and have a synergistic effect, the NAD < + > content of skin tissues and cells can be effectively increased, inflammatory factor generation caused by ultraviolet rays is effectively reduced, enrichment of active oxygen and advanced glycosylation end products is reduced, and light damage and light aging of the skin caused by the ultraviolet rays or blue light are relieved. The compound has a very good application prospect in products for preventing, relieving and / or treating light damage or / or light aging.
Owner:BY HEALTH CO LTD

Formula for beauty and complexion-enhancing agent

A formula for a beauty and complexion-enhancing agent, comprising the following raw materials: 12-15 parts of Polygonum multiflorum Thunb., 9-12 parts of Angelica dahurica, 4-6 parts of Aconiti Lateralis Radix Praeparata, 6-8 parts of honey, 0.1-0.3 parts of sodium hyaluronate, and 3-4 parts of ginger juice. The advantages of the invention are as follows: the processed Aconiti Lateralis Radix Praeparata effectively reduces its toxicity, while the other ingredients are all natural components, causing minimal skin irritation, making it safe and reliable to use; by combining Polygonum multiflorum Thunb., Angelica dahurica, and Aconiti Lateralis Radix Praeparata, the formula provides multiple effects including hydrating and locking in moisture, improving skin dryness and roughness, reducing scars, alleviating acne inflammation, and decreasing pigmentation, thereby comprehensively improving skin condition.

Cosmetic use of the oily extract of the solid residue of the immortelle as a skin lightening agent

The present invention relates to the cosmetic use of an oily extract of the solid residues of preserved flowers as a skin lightening agent. It also relates to a cosmetic composition comprising, in a physiologically acceptable medium, an oily extract of the residues of preserved flowers and hexylresorcinol; and the use of this composition.
Owner:LAB M&L SA

Skin whitening agent composition

PendingCN121154502ACosmetic preparationsToilet preparationsANGELICA ROOT EXTRACTPolygonatum
The invention relates to the technical field of skin care products, and particularly discloses a skin whitening agent composition. The skin whitening agent composition is prepared from the following components in parts by mass: 11.87 to 19.39 parts of a humectant; 4.95 to 10.75 parts of a whitening agent; 0.35 to 1.05 parts of a skin conditioning agent; 66.85 to 81.55 parts of a solvent; 1.28 to 1.96 parts of an auxiliary agent; the skin conditioner is prepared by compounding a poria cocos extract, a mulberry root bark extract, a Chinese herbaceous peony root extract, a chrysanthemum extract, a radix ampelopsis root extract, a bighead atractylodes rhizome root extract, a dictamnus dasycarpus root extract, a radix polygonati officinalis extract, a mangnolia officinalis bark extract, an angelica sinensis root extract and a rhizoma bletillae root extract; the whitening agent is prepared by compounding glabridin, nonapeptide-1, nicotinamide, azelamide MEA, tranexamic acid, glutathione, acetylchitosamine and papain. The whitening mask has the advantage of better whitening effect.
Owner:广东雅心生物技术有限公司

Compositions and Methods for Treating Skin Discoloration

Disclosed in certain embodiments herein is a topical formulation including a tyrosine inhibitor, a skin brightener, and a resorcinol compound. The topical formulation does not include hydroquinone to comply with new federal regulations. A delivery system and method of treating hyperpigmentation is also provided.
Owner:RACQUEL FRISELLA LLC

Hydrogenated genipin derivatives attachable to keratinous tissue

The present application relates to topical compositions comprising a compound capable of covalently binding to the skin and an excipient suitable for topical application wherein the compound capable of covalently binding to the skin is a compound of formula (I) or a tautomer and / or a pharmaceutically acceptable salt thereof, wherein R1 represents hydrogen or a protecting group that is hydrolysable under physiological conditions upon application of the topical composition to the skin; wherein L1, L2 and L3, independently of each other, represent a linking group or are absent, and wherein A1, A2 and A3, independently of each other, represent: a) a C1-C30 moiety, H, hydroxyl, amino or halogen, or b) a C1-C60 moiety or a polymeric moiety; wherein at least one of A1, A2 and A3 is a C1-C60 moiety or a polymeric moiety of group b); wherein the C1-C60 portion or polymeric portion of group b): b1) is configured to act as a skin moisturizer, an insecticide, a skin whitening agent or a drug; and / or b2) is configured to act as a skin moisturizer, an insecticide, a skin whitening agent, a fragrance or a drug upon cleavage from the 3, 4-dihydro-2H-pyran moiety; and wherein L1-A1 and L2-A2 do not represent a moiety comprising an unsaturated C-C or C-N bond at the alpha position of the carbon atoms marked as "a" and "b", respectively. (I);
Owner:BEACON CORP

Derivatives of elenolic acid attachable to keratinous tissues

The present disclosure relates to novel uses, compounds and topical compsitions of a compound of formula (I) comprising a 3,4-saturated 2H-pyran moiety,, for covalently binding to a substrate comprising amino groups, and in particular to skin and / or to hair; wherein the compound of formula (I) covalently binds to the substrate by the reaction of its 3,4-saturated 2H-pyran moiety with the amino groups comprised by the substrate; wherein the compound of formula (I), after having covalently bound to the substrate, is providing color to the substrate, and / or binds one or more active ingredients to the substrate; wherein, if active ingredient(s) is(are) present, the one or more active ingredients are, in particular and independently from each other, selected from a moisturizer, a pesticide, a fragrance, a pharmaceutical, a skin whitening agent, UVA- and / or UVB-absorbing moiety, a color-imparting moiety, a cosmetic hair coating agent, and a primer for attaching dyes to hair; wherein the compound of formula (I) comprises the one or more active ingredients, if present, independently from each other: a) as the active ingredient, or b) as a precursor of the active ingredient, wherein the compound of formula (I) is cleavable to release the active ingredient from the precursor after the application of the compound of formula (I) to the substrate (in the following: "the corresponding precursor thereof"); and c) wherein one of A1 and A2 represents said active ingredient or the corresponding precursor thereof; wherein L1 and L2 represent, independently from each other, a linker group or are absent; wherein each of A1 and A2 not representing one of the one or more active ingredients and precursors represents hydrogen, a C1-C30 moiety, hydroxyl, amino, or a halogen; wherein R1 represents hydrogen or a protective group hydrolysable after application of the compound of formula (I) to the substrate; wherein R2 and R3 independently from each other represent H or a C1-C30 moiety; and wherein the compound is not oleuropein aglycone, elenolic acid, or a tautomer and / or a pharmaceutically acceptable salt thereof.
Owner:BIC INC